Chemical formula: C₁₇H₂₂I₃N₃O₈ Molecular mass: 777.085 g/mol PubChem compound: 65492
Iopamidol is contrast medium belonging to the new generation of non-ionic compound whose solubility is due to the presence of hydrophilic substitutes in the molecule. This results in a solution of low osmollity when compared with ionic media.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V08AB04 | Iopamidol | V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| ISOVUE 200/250/300/370 Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| NIOPAM Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| GASTROMIRO Solution for oral or rectal administration | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Iopamidol is an active ingredient of these brands:
United States (US)Austria (AT)
Brazil (BR)Canada (CA)Croatia (HR)
Estonia (EE)
France (FR)Hong Kong (HK)
Ireland (IE)Japan (JP)Lithuania (LT)
Romania (RO)
Singapore (SG)
Turkey (TR)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
